Jun 18, 2026 06:47AM
Jun 15, 2026 09:25AM
Jun 12, 2026 08:00AM
Jun 1, 2026 07:31AM
Jun 1, 2026 06:57AM
May 6, 2026 07:05AM
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Apr 2, 2026 06:45AM
Apr 1, 2026 08:02AM
Mar 22, 2026 10:00AM
Mar 16, 2026 09:57AM
Mar 16, 2026 08:02AM
Feb 18, 2026 07:23AM
Jan 26, 2026 08:02AM Cogent Biosciences gets FDA breakthrough therapy status for GIST drug combo
Jan 20, 2026 08:02AM
Jan 14, 2026 06:54AM
Jan 13, 2026 01:28PM
Jan 12, 2026 03:47PM
Jan 12, 2026 08:07AM
Jan 7, 2026 10:15AM
Jan 7, 2026 12:41AM UBS Starts Cogent (COGT) at Buy
Jan 6, 2026 06:42AM
Dec 30, 2025 09:46AM
Dec 30, 2025 08:02AM
Dec 8, 2025 02:11PM
Dec 8, 2025 08:38AM
Dec 8, 2025 07:35AM
Dec 8, 2025 07:31AM Cogent Biosciences reports positive APEX trial results for bezuclastinib
Dec 8, 2025 02:54AM
Dec 3, 2025 10:52AM
Dec 2, 2025 10:19AM
Nov 11, 2025 04:27AM
Nov 10, 2025 01:18PM
Nov 10, 2025 10:54AM
Nov 10, 2025 10:10AM Wedbush Upgrades Cogent (COGT) to Outperform
Nov 10, 2025 10:02AM
Nov 7, 2025 04:53PM
Oct 24, 2025 12:30PM
Oct 24, 2025 08:29AM
Oct 15, 2025 04:10PM
Sep 23, 2025 12:00PM
Sep 22, 2025 05:06AM Raymond James Reiterates Strong Buy Rating on Cogent (COGT), 'Remains a Top Pick After CEO Fireside Chat'
Sep 16, 2025 06:44AM
Aug 25, 2025 07:16AM
Aug 5, 2025 03:26PM
Aug 5, 2025 10:20AM
Jul 18, 2025 04:56AM
Jul 10, 2025 04:02PM
Jul 9, 2025 05:59AM Cogent Biosciences prices $200 million stock offering at $9 per share
Jul 8, 2025 04:49PM

416,808 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All